LLY Short Volume

Eli Lilly and Company (LLY) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry, with a market capitalization near $1.11T, listed on NYSE, employing roughly 50,000 people, carrying a beta of 0.51 to the broader market. Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Led by David A. Ricks, public since 1972-06-01.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-08-14
Short Volume
418.5K
Total Volume
841.3K
Short %
49.74%
30-Day Avg Short %
42.82%

Showing 30 days of FINRA short volume data for Eli Lilly and Company.

Learn how short volume is reported and how to read the data →

Frequently asked LLY short volume questions

What is the daily LLY short volume?
As of Aug 14, 2026, Eli Lilly and Company (LLY) short volume is 418.5K shares against 841.3K total reported volume, or 49.74% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is LLY short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does LLY short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.